Follow
Ken Eng
Ken Eng
Verified email at Illumina.com - Homepage
Title
Cited by
Cited by
Year
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
38942015
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
et al Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y ...
Blood 125 (7), 1061-72, 2015
371*2015
Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
SCK David Chiron, Maurizio Di Liberto, Peter Martin, Xiangao Huang, Jeff ...
Cancer Discovery, 2014
3242014
Whole-exome sequencing of metastatic cancer and biomarkers of treatment response
H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ...
JAMA Oncology 1 (4), 466-474, 2015
3162015
Increased serine and one-carbon pathway metabolism by PKCλ/ι deficiency promotes neuroendocrine prostate cancer
M Reina-Campos, JF Linares, A Duran, T Cordes, A L'Hermitte, MG Badur, ...
Cancer Cell 35 (3), 385-400. e9, 2019
1782019
Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas
Y Jiang, D Redmond, K Nie, KW Eng, T Clozel, P Martin, LHC Tan, ...
Genome biology 15, 1-17, 2014
1272014
Patient-derived xenografts and organoids model therapy response in prostate cancer
S Karkampouna, F La Manna, A Benjak, M Kiener, M De Menna, E Zoni, ...
Nature communications 12 (1), 1117, 2021
1152021
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care
H Rennert, K Eng, T Zhang, A Tan, J Xiang, A Romanel, R Kim, W Tam, ...
npj Genomic Medicine 1, 16019, 2016
862016
Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models
DJ Pisapia, S Salvatore, C Pauli, E Hissong, K Eng, D Prandi, VW Sailer, ...
JCO precision oncology 1, 1-13, 2017
532017
The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer
W Liu, KP Newhall, F Khani, LM Barlow, D Nguyen, L Gu, K Eng, ...
Cancer Research 83 (4), 506-520, 2023
222023
CCMCL1: a new model of aggressive mantle cell lymphoma
X Zhao, S Chen-Kiang, S Shetty, M Di Liberto, J Bodo, L Durkin, K Eng, ...
Blood, The Journal of the American Society of Hematology 125 (17), 2730-2732, 2015
92015
Exome sequencing of purified Hodgkin Reed-Sternberg cells reveals recurrent somatic mutations in genes responsible for antigen presentation, chromosome integrity …
JB Reichel, K Eng, O Elemento, E Cesarman, M Roshal
Blood 122 (21), 625, 2013
62013
The cytidine deaminase APOBEC3G drives cancer mutagenesis and clonal evolution in bladder cancer
W Liu, KP Newhall, F Khani, LM Barlow, D Nguyen, L Gu, K Eng, ...
bioRxiv, 2022.09. 05.503899, 2022
12022
Germline Variants and Secondary Findings in a Cancer Precision Medicine Cohort
T Zhang, A Romanel, MJ Kluk, K Eng, I Iossifov, A Sboner, S Lipkin, ...
Laboratory Investigation 96, 461A-461A, 2016
12016
EXaCT-2: An augmented and customizable oncology-focused whole exome sequencing platform
PH Waltman, P Chandra, KW Eng, DC Wilkes, H Park, C Pabon, T Kane, ...
medRxiv, 2024.12. 05.24318515, 2024
2024
Prognosis Determined by Tumor Mutational Burden (TMB) Using Whole Exome Sequencing (WES)
E Fernandez, K Eng, A Sboner, O Elemento, W Song
JOURNAL OF MOLECULAR DIAGNOSTICS 20 (6), 1013-1013, 2018
2018
Deep Sequencing Reveals Clonal Evolution Patterns and Mutation Events Associated With Relapse In B Cell Lymphomas
Y Jiang, D Redmond, K Nie, K Eng, T Clozel, P Martin, L Tan, AM Melnick, ...
Blood 122 (21), 79, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–17